Qube Research & Technologies LTD Kala Pharmaceuticals, Inc. Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.25 - $11.7 $800 - $37,475
-3,203 Reduced 10.23%
28,116 $6,000
Q2 2022

Aug 15, 2022
BUY
$0.3 - $1.31 $9,395 - $41,027
31,319 New
31,319 $9,000
Q3 2020

Nov 12, 2020
SELL
$7.5 - $11.11 $322,132 - $477,185
-42,951 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$8.33 - $13.79 $357,781 - $592,294
42,951 New
42,951 $451,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Kala Pharmaceuticals, Inc.

KALA Quotes by TradingView
  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $9.05M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email